# MyoPowers Medical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myopowers-medical-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Lausanne, Switzerland
- Website: www.myopowers.com
- Total disclosed funding: $23M
- Latest round: Series B (Jul 5, 2011)
- Investors on record: 6

## About

MyoPowers Medical Technologies SA is a Swiss company focused on developing innovative medical technologies, particularly in the realm of muscle power and rehabilitation solutions, aimed at enhancing patient care and recovery.Founded in 2004 in Lausanne, Switzerland, MyoPowers Medical Technologies SA specializes in medical technology solutions. The company has undergone strategic developments, including securing significant funding to advance its innovative offerings. Its most recent funding was a Series B round on July 5, 2011, led by Truffle Capital, raising CHF 16 million. MyoPowers has completed a total of 2 deals, with this round marking the total amount raised to CHF 16 million. No specifics on subsidiaries or founders' prior ventures are available.MyoPowers Medical Technologies SA provides advanced software applications designed to enhance operational efficiency in medical technologies. These solutions integrate seamlessly with existing medical infrastructures, optimizing workflows and improving productivity for various healthcare providers. Their diverse clientele spans North America, Europe, and Asia-Pacific, addressing critical industry challenges like data management and patient engagement. The products have been released over several years, gaining traction for their user-friendly interfaces and comprehensive features.MyoPowers Medical Technologies SA operates on a subscription revenue model, allowing clients to access its software services consistently. Clients enter into direct agreements based on their needs, subscribing to various service tiers. The firm’s flagship products come with features tailored for operational enhancement, fostering long-term partnerships and generating a stable revenue stream that supports ongoing financial health.MyoPowers Medical Technologies SA plans to leverage the recent CHF 16 million Series B funding, led by Truffle Capital, to enhance its product offerings and expand into new markets. The goal includes launching new innovative solutions within the next two years, aimed at further optimizing patient care and rehabilitation technologies. The company targets expansion into emerging markets in Asia and the Middle East by 2025, capitalizing on the increasing demand for advanced medical technologies in these regions.

## Funding rounds

- Series B, Jul 5, 2011, $19M — Truffle Capital, Novartis Venture Fund, Blue Ocean Ventures, Initiative Capital Romandie, Gran Plasa SA
- Series A, Jun 1, 2010, $4.3M — Novartis Venture Fund, MyoPowers Medical Technologies SA, Initiative Capital Romandie, Gran Plasa SA

## Investors

- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B
- MyoPowers Medical Technologies SA — Series A
- Initiative Capital Romandie — Series A, Series B
- Gran Plasa SA — Series A, Series B
- Truffle Capital (https://capitalatlas.ai/funds/truffle-capital) — Series B
- Blue Ocean Ventures (https://capitalatlas.ai/funds/blue-ocean-ventures) — Series B